IntegraDose Vasopressin syringes recalled for subpotent drug content
IntegraDose Compounding Services LLC is recalling Vasopressin 2 Units/2 mL syringes because the drug may contain less active ingredient than labeled. This affects two specific lots distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Check if you have syringes from lot 20260327VAS-3 (expires 05/26/2026) or lot 20260320VAS-3 (expires 05/19/2026).
- Contact your pharmacy or healthcare provider if you have received these syringes.
- Do not use the recalled syringes without consulting your provider.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.
- Sold in
- Nationwide
Details
- Units affected
- 287 units
- Illnesses reported
- None reported
- Manufactured in
- 3650 Victoria St N Ste 900, Shoreview, MN, United States
- Classification
- Class II
- Recall number
- D-0593-2026
In the FDA's words
- Description
- Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1. Subpotent Drug Lot#: 20260327VAS-3, BUD: 05/26/2026; 20260320VAS-3, BUD: 05/19/2026. Distribution: U.S.A. Nationwide Affected quantity: 287 units
- Hazard
- Subpotent Drug